Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer.
Author(s) -
T W Zhang,
G B Rodrigues,
A V Louie,
D Palma,
A R Dar,
B Dingle,
W Kocha,
M Sanatani,
B Yaremko,
E Yu,
J Younus,
M D Vincent
Publication year - 2018
Publication title -
current oncology (toronto, ont.)
Language(s) - English
Resource type - Journals
pISSN - 1198-0052
DOI - 10.347/co.25.3657
We designed a phase i study of concurrent chemoradiotherapy (ccrt) with docetaxel (D) and cisplatin (C), followed by consolidation dc, for unresectable stage iii non-small cell lung cancer (nsclc).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom